Diana Dee Starlight Tampil Seksi saat Tes Swab, Netizen: Petugasnya Auto Keringat Dingin!

DIANA Dee Starlight mencuri perhatian netizen lewat unggahan terbarunya di Instagram. Artis asal Manado tersebut tampil seksi dalam video berdurasi singkat yang bikin netizen gagal fokus.

Dalam video tersebut memperlihatkan Diana Dee Starlight sedang menjalani tes Swab. Tes terlihat seperti pada umumnya, tapi penampilan Diana Dee yang menjadi sorotan netizen.

Diana Dee Starlight

Diana Dee tampil seksi dalam balutan outfit warna kuning. Dress dengan belahan terbuka membuat ‘aset’ Diana Dee menjadi terekspos.

BACA JUGA : Diana Dee Starlight Seksi Pakai Kebaya Transparan, Netizen Salfok ke Emoji

Alhasil, meskipun mencoba menutupi dengan memangku boneka anjing, penampilan Diana Dee tetap seksi menggoda. Gayanya makin kece dengan memakai topi rajut.

Diana Dee Starlight

BACA JUGA : Bra Menerawang Diana Dee Starlight Bikin Salfok, Netizen: Sampai Kebawa Mimpi!

Sementara itu, usai menjalani swab, Diana Dee pun menebar senyuman ke kamera yang membuatnya semakin cantik. Netizen pun dibuat terpesona melihat senyum dan penampilan seksi Diana Dee.

“Geulis pisan😍😍😍,” puji @handriyan

“😍❤️cantik bangett,” sambung @ekapriyad

“Fokus… Fokus… Fokus!!!,” komen @mr.da

“Dasar ny cantik mau d apain jga tetep aja cantik,” celetuk @yunussun

“Aduhh neng.. Galfok jdinya,” celetuk @ichuk_d

“Woow cantik sexy banget 🥰😘😋😋😋,” ujar @yudi.yudii.1

“Yg ngeswab gak gemeteran tuh😂,” tutur @raskha.roc

“Petugasnya auto keringet dingin😢,” kata @fpwib

(hel)

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Preauthorization Slows Treatment; Taxing Cancer Away; HPV Saliva Test thumbnail

Preauthorization Slows Treatment; Taxing Cancer Away; HPV Saliva Test

Prescriptions for most anticancer drugs require prior authorization, which increases the time until patients begin receiving the drugs. (ASCO Quality Care Symposium) Exelixis announced FDA approval of cabozantinib (Cabometyx) for children and adults with radioactive iodine-refractory, locally advanced/metastatic differentiated thyroid cancer previously treated with VEGF receptor-targeted therapy. Seagen and Genmab announced FDA accelerated approval of…
Read More

Ministry of Health reduces interval of the third dose against Covid-19 to four months

Avalie o nosso conteúdo: Houve um erro fazendo sua requisição, por favor tente novamente! Obrigado!Sua avaliação é fundamental para que a gente continue melhorando o Portal Pebmed O Portal PEBMED é destinado para médicos e demais profissionais de saúde. Nossos conteúdos informam panoramas recentes da medicina. Caso tenha interesse em divulgar seu currículo na internet,…
Read More
How retail became healthcare’s biggest disruptor thumbnail

How retail became healthcare’s biggest disruptor

Skip to main content Mega-retailers are stepping in to improve the way healthcare is delivered, disrupting a status-quo industry that has been slow to change. Retailers ranging from drugstore chains to discount superstores are looking to take market share from traditional hospitals and health systems by stressing a more customer-centric focus. In many markets, the
Read More
First AKT Inhibitor Approved for Advanced Breast Cancer thumbnail

First AKT Inhibitor Approved for Advanced Breast Cancer

Oncology/Hematology > Breast Cancer — Capivasertib plus fulvestrant doubled progression-free survival versus fulvestrant-placebo by Charles Bankhead, Senior Editor, MedPage Today November 17, 2023 The FDA approved the first-in-class AKT inhibitor capivasertib (Truqap), in combination with fulvestrant, for locally advanced/metastatic hormone receptor (HR)-positive/HER2-negative breast cancer and at least one specific genetic alteration. The approval stipulates use
Read More
Index Of News
Total
0
Share